Clover Corporation Limited (ASX:CLV)

Market Cap	128.59M +102.6%
Revenue (ttm)	86.00M +38.3%
Net Income	7.02M +382.5%
EPS	0.04 +382.8%
Shares Out	167.00M
PE Ratio	18.33
Forward PE	15.10
Dividend	0.02 (2.56%)
Ex-Dividend Date	Oct 20, 2025

Volume	133,832
Average Volume	181,647
Open	0.7700
Previous Close	0.7800
Day's Range	0.7700 - 0.7800
52-Week Range	0.3370 - 0.8650
Beta	-0.04
RSI	45.84
Earnings Date	Mar 12, 2026

About Clover Corporation

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega’s Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. Clover Corporation Limited was incorporated in 1988 and is headquarte...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1988
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CLV

Financial Performance

In fiscal year 2025, Clover Corporation's revenue was 86.00 million, an increase of 38.25% compared to the previous year's 62.21 million. Earnings were 7.02 million, an increase of 382.46%.